• 1. An artificial enzyme cascade amplification strategy for highly sensitive and specific detection of breast cancer-derived exosomes?
  Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549
• 2. An Appraisal of pH triggered Bacitracin drug release, through composite hydrogel systems
  RabailGul,MariamMir,MurtazaNAli
• 3. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 4. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210
• 5. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782

Methyl 3-(Naphthalen-2-yl)-1H-pyrazole-5-carboxylate (CAS No. 164295-93-6): A Comprehensive Review of Its Chemical Properties and Applications

Methyl 3-(naphthalen-2-yl)-1H-pyrazole-5-carboxylate, identified by its CAS number 164295-93-6, is a significant compound in the realm of organic chemistry and pharmaceutical research. This heterocyclic compound features a pyrazole core linked to a naphthalene moiety, making it a versatile scaffold for various chemical modifications and biological evaluations. The unique structural attributes of this molecule have garnered considerable attention from researchers exploring novel pharmacophores and synthetic pathways.

The molecular structure of methyl 3-(naphthalen-2-yl)-1H-pyrazole-5-carboxylate consists of a pyrazole ring substituted at the 3-position with a naphthalene group, which is further esterified at the 5-position with a methyl group. This configuration imparts distinct electronic and steric properties, making it an attractive candidate for further functionalization. The presence of both aromatic and heterocyclic components in its structure suggests potential interactions with biological targets, which has been a driving force behind its exploration in drug discovery.

In recent years, the pharmaceutical industry has witnessed a surge in the development of molecules incorporating pyrazole and naphthalene motifs due to their proven efficacy in modulating various biological pathways. Studies have demonstrated that compounds containing these structural elements often exhibit inhibitory activity against enzymes and receptors involved in inflammatory responses, cancer progression, and neurological disorders. The naphthalen-2-yl substituent, in particular, has been shown to enhance binding affinity and selectivity, making it a valuable component in designing targeted therapeutics.

One of the most compelling aspects of methyl 3-(naphthalen-2-yl)-1H-pyrazole-5-carboxylate is its synthetic accessibility. The compound can be readily prepared through multi-step organic synthesis involving condensation reactions, cyclization processes, and esterification steps. These synthetic routes not only highlight the versatility of the starting materials but also provide opportunities for introducing additional functional groups, thereby expanding the chemical space for further derivatization. The ease with which this compound can be modified has made it a preferred choice for medicinal chemists seeking to develop novel analogs with enhanced pharmacological properties.

The biological activity of methyl 3-(naphthalen-2-yl)-1H-pyrazole-5-carboxylate has been extensively studied in various preclinical models. Research has indicated that this compound exhibits promising inhibitory effects on enzymes such as cyclooxygenase (COX) and lipoxygenase (LOX), which are key players in the pathogenesis of inflammation and pain. Furthermore, preliminary studies suggest that it may interact with receptors involved in cancer cell proliferation and apoptosis, positioning it as a potential candidate for oncology applications.

Advances in computational chemistry have further facilitated the exploration of methyl 3-(naphthalen-2-yl)-1H-pyrazole-5-carboxylate. Molecular docking simulations have been employed to predict its binding interactions with target proteins, providing insights into its mechanism of action. These computational studies have complemented experimental efforts by identifying key residues involved in binding and suggesting optimal conditions for further optimization. The integration of computational methods with traditional experimental approaches has significantly accelerated the drug discovery process, enabling faster identification of lead compounds.

The chemical stability and solubility profile of methyl 3-(naphthalen-2-yl)-1H-pyrazole-5-carboxylate are also critical factors to consider in its potential application as a pharmaceutical intermediate. Preliminary data suggest that the compound exhibits good stability under standard storage conditions but may require specific solvents or formulations for optimal solubility in biological systems. Efforts are ongoing to enhance its physicochemical properties through structural modifications, ensuring better bioavailability and therapeutic efficacy.

In conclusion, methyl 3-(naphthalen-2-yl)-1H-pyrazole-5-carboxylate (CAS No. 164295-93-6) represents a fascinating compound with significant potential in pharmaceutical research. Its unique structural features, synthetic accessibility, and promising biological activities make it an attractive scaffold for developing novel therapeutics. As research continues to uncover new applications and optimize its properties, this compound is poised to play a crucial role in addressing various medical challenges.

• 144252-20-0(methyl 3-(pyridin-4-yl)-1H-pyrazole-5-carboxylate)
• 164295-94-7(3-(2-naphthyl)-1{H}-pyrazole-5-carboxylic acid)
• 5932-30-9(Ethyl 3-phenyl-1H-pyrazole-5-carboxylate)
• 192701-73-8(methyl 3-(4-methylphenyl)-1H-pyrazole-5-carboxylate)
• 856061-37-5(methyl 2-phenyl-1H-imidazole-4-carboxylate)
• 13599-12-7(Ethyl 3-phenylpyrazole-5-carboxylate)
• 56426-35-8(Methyl 3-phenyl-1H-pyrazole-5-carboxylate)
• 181706-69-4(6-phenyl-3-Pyridazinecarboxylic acid methyl ester)
• 942040-15-5(Ethyl 5-(2-methylphenyl)-2H-pyrazole-3-carboxylate)
• 595610-41-6(Ethyl 5-(4-methylphenyl)-2H-pyrazole-3-carboxylate)